ENTITY
Takeda Pharmaceutical

Takeda Pharmaceutical (4502 JP)

342
Analysis
Health Care • Japan
Takeda Pharmaceutical Co Ltd focuses on the Research & Development, Manufacturing, Sales and Marketing and Import/Export of Pharmaceutical Drugs. The Company focuses on the following core therapeutic areas: Cardiovascular & Metabolic, Oncology, Central Nervous System, Respiratory & Immunology, General Medicine (Gastrointestinal & Genitourinary) and Vaccine.
more
•23 Apr 2018 13:49

The Week That Was in NorthAsia@Smartkarma: Itochu/FamilyMart, Samsung, Suruga, & Renesas

Below is the full list of Japan/Korea related reports published last week on Smartkarma.Itochu Tender For FamilyMartTravis Lundy explained the...

Logo
378 Views
Share
bullish•Daiichi Sankyo
•13 May 2026 08:30

Daiichi Sankyo (4568 JP): Ends FY26 on Mixed Note; It’s Time to Focus on Innovation Prowess

​Daiichi Sankyo aims to become a global top five oncology company with ¥2.3T+ oncology revenue by 2030, by maximize the value of its DXd ADC...

Logo
98 Views
Share
•20 Apr 2018 18:16

Japan Pharmaceuticals: The Week that Was…

Nippon Shinyaku Co Ltd (4516 JP) @ ÂĄ 8,480 (up ~18% week-to-date) vs. our TP ÂĄ 8,600. We recommend booking profit at current levels. Takeda...

•13 Apr 2018 17:33

Japan Pharmaceuticals: The Week that Was…

Takeda Pharmaceutical Co Ltd (4502 JP) @ ÂĄ 4,911/ share (down 24% YTD) implies ~17x (~30% discount to industry average) our FY19e core EPS of ÂĄ...

•09 Apr 2018 09:03

The Week That Was In North Asia@Smartkarma: JDI, Renesas, Trade, Governance, and Mobis/Glovis

It was a "slow" week on Smartkarma with 'only' 165 pieces of research published, but it is school vacation week in Asia, with two days off in Hong...

Logo
343 Views
Share
x